EUVIMEDEUVIMED entdecken
Crossref

Current status of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) targeting cancer therapy

Eiji Mori, Kazuhiro Motoki, Shiro Kataoka

Annals of Cancer Research and Therapy · 2005

DOI: 10.4993/acrt.13.11 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Cancer Research and Therapy, 2005. Verfasst von Eiji Mori und 2 weiteren Autor:innen. Die Arbeit nennt 64 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Mori, E., Motoki, K., & Kataoka, S. (2005). Current status of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) targeting cancer therapy. Annals of Cancer Research and Therapy. https://doi.org/10.4993/acrt.13.11

Vancouver

Mori E, Motoki K, Kataoka S. Current status of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) targeting cancer therapy. Annals of Cancer Research and Therapy. 2005. doi:10.4993/acrt.13.11

BibTeX
@article{Mori2005,
  author = {Mori, Eiji and Motoki, Kazuhiro and Kataoka, Shiro},
  title = {Current status of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) targeting cancer therapy},
  journal = {Annals of Cancer Research and Therapy},
  year = {2005},
  doi = {10.4993/acrt.13.11}
}
Kostenlos starten →